Residual Hearing - Public Sports

Business Wire: Sensorion Announces it Has Met Primary Endpoint for SENS-401 Phase 2a Clinical Study for Residual Hearing Preservation Sensorion Announces it Has Met Primary Endpoint for SENS-401 Phase 2a Clinical Study for Residual Hearing Preservation After a disappointment with the same product in another indication about two years ago, Sensorion SA met the primary endpoint in its proof-of-concept phase IIa trial with SENS-401 for residual hearing ... Many hearing-impaired children learn sign language or read lips, but others depend on their residual hearing. A new pre-school program in Wake County pairs these children with hearing students.

FierceBiotech: Sensorion candidate reduces hearing loss in small midphase trial, offering hope after earlier flop Sensorion’s bid to rebuild confidence in its hearing loss drug candidate SENS-401 has gathered another data point. After seeing the small molecule fail in one indication last year, the French biotech ... Sensorion candidate reduces hearing loss in small midphase trial, offering hope after earlier flop EurekAlert!: New active substance for the treatment of acute sudden hearing loss